Inherently radiopaque polymeric products for embolotherapy
US8685367B2 · kind B2 · utility
32Cited by
28References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 27, 2004 |
| Grant date | Apr 1, 2014 |
| Priority date | — |
| Expiry date | Jun 28, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Preferred embodiments relate to compositions of inherently radiopaque, biocompatible, bioresorbable polymeric particles and methods of using them for embolizing a body lumen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.